A Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or Hemodialysis
PHASE3
The objective is to evaluate the safety of paricalcitol capsules in pediatr...
Study to Assess Patient Management Practices and Quality of Life With Paricalcitol Capsules in the Treatment of Secondary Hyperparathyroidism in Stage 3-5 Chronic Kidney Disease Patients Not Yet on Dialysis
N/A
Paricalcitol capsules (Zemplar®) received marketing authorization in Sweden...
Status
Completed
Location
Site Reference ID/Investigator# 47723
Start Date
2011-02
Trial ID
NCT01265992
Paricalcitol Versus Calcitriol for the Management of Renocardiac Syndrome in Renal Transplant Patients
PHASE4
We hypothesize that paricalcitol and calcitriol in dose-dependent manner ar...
Paricalcitol in Reducing Parathyroid Hormone Levels and Ameliorating Markers of Bone Remodelling in Renal Transplant Recipients With Secondary Hyperparathyroidism
PHASE2
The risk of fracture for kidney transplant recipients is 4 times higher tha...
Status
Completed
Location
Mario Negri Institute - Clinical Research Center for Rare Diseases